Latest DEF 14A proxy statements

HF Foods Group Inc. releases its 2026 proxy statement detailing executive compensation, director elections, and strategic operational progress.

Universal Insurance Holdings, Inc. has released its 2026 Proxy Statement detailing director elections, executive compensation, and auditor ratification.

Karat Packaging Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation votes.

DigitalOcean Holdings, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation disclosures.

Cronos Group Inc. has scheduled its 2026 Annual Meeting of Shareholders for June 18, 2026, to be held in a virtual-only format.

Tectonic Therapeutic, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 8, 2026, to address director elections, auditor ratification, and executive compensation.

Orion S.A. has issued its 2026 proxy statement detailing the agenda for the upcoming Annual General Meeting of Shareholders scheduled for June 25, 2026.

Nasdaq's 2026 proxy statement highlights record 2025 financial performance, successful Adenza integration, and an AI-first strategic roadmap.

Green Plains Inc. filed its 2026 Proxy Statement detailing director elections, executive compensation, and a proposal to increase shares available under its 2019 Equity Incentive Plan.

Amplitude, Inc. has filed its 2026 proxy statement detailing the upcoming annual meeting of stockholders scheduled for June 9, 2026.

Centrus Energy Corp. reports robust 2025 financial and operational performance, including significant HALEU production and a large LEU backlog, while seeking shareholder approval for director elections, executive compensation, officer exculpation, and an amended Section 382 Rights Agreement.

McEwen Inc. announces its 2026 Annual Meeting of Shareholders to be held on June 4, 2026, to vote on director elections, auditor ratification, and share issuance to Robert McEwen.

AMERISAFE, Inc. has filed its 2026 proxy statement detailing director elections, executive compensation, and proposed amendments to its Certificate of Formation.

Adaptive Biotechnologies Corporation announces its 2026 Annual Meeting of Shareholders to be held virtually on June 5, 2026.

Zeta Global Holdings Corp. announces its 2026 Annual Meeting of Stockholders to be held on June 16, 2026, to vote on director elections, auditor ratification, and executive compensation.

CG Oncology, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 4, 2026.

Ingersoll Rand Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 11, 2026.

Maravai LifeSciences announces its 2026 Annual Meeting of Shareholders to be held virtually on May 26, 2026.

Willdan Group, a professional services company, announced record financial results for fiscal year 2025 and outlined proposals for its 2026 Annual Meeting, including an increase in its performance incentive plan shares.

Kalaris Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 3, 2026.

BridgeBio Pharma, Inc. has filed its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation proposals.

ZipRecruiter, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 9, 2026.

Infinity Natural Resources, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 9, 2026.

Savara Inc. seeks stockholder approval for a share authorization increase and amendments to its 2024 Omnibus Incentive Plan ahead of potential commercialization.

CAVA Group, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 22, 2026.

Instil Bio, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 11, 2026.

Apogee Therapeutics, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory vote.

IMAX Corporation reports record 2025 financial performance and outlines proposals for its 2026 Annual General Meeting, including executive compensation and director elections.

VirnetX Holding Corporation announced its 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026, where key proposals include director elections, auditor ratification, executive compensation advisory vote, and an amendment to increase the equity incentive plan's share reserve by 1,000,000 shares.

Enovix Corporation's 2026 Proxy Statement details 2025 operational progress, executive compensation structures, and upcoming annual meeting agenda.